An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)
Clinical trial NCT02354846 · UNKNOWN
Trial details
- NCT number
- NCT02354846
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-01
- Primary completion
- 2021-03-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.